Tencent stock slips despite HK$636 million buyback — traders eye March results and dividend
10 January 2026
1 min read

Tencent stock slips despite HK$636 million buyback — traders eye March results and dividend

Hong Kong, Jan 10, 2026, 23:24 (HKT) — Market closed.

  • Tencent shares dipped 0.81% to close at HK$611.00 on Friday, down from Thursday’s HK$616.00.
  • A filing with the Hong Kong Exchange revealed Tencent bought back 1.039 million shares, shelling out HK$635.9 million at prices between HK$610.50 and HK$616 apiece.
  • Tencent will hold a board meeting on March 18 to approve its 2025 annual results and discuss a final dividend.

Tencent Holdings’ shares on the Hong Kong market slipped Friday, despite the company announcing a fresh batch of buybacks.

The stock ended the day at HK$611.00, slipping 0.8%.

Repurchases stand out as a sharp, near-term indicator of how Tencent plans to deploy cash given current prices. By buying stock on the open market, buybacks reduce the number of shares outstanding, often aiming to boost earnings per share.

All eyes turn to March, when Tencent’s board will review the 2025 annual results and decide on a final dividend. This timing brings shareholder returns back into focus, alongside growth.

Tencent’s filing revealed it repurchased just over a million shares on Jan. 9, spending roughly HK$636 million. The shares traded mostly in the low HK$610s range. The company confirmed these shares were bought back for cancellation.

Hong Kong tech stocks have been volatile this week, as investors flock to fresh AI and chip listings. “China’s AI story is only beginning to unfold, so it’s too early to draw conclusions,” said Marco Sun, chief financial market analyst at MUFG (China), following a string of China tech IPO launches.

The broader Hong Kong market edged higher on Friday, with the Hang Seng Index rising 0.32% and the Hang Seng Tech Index climbing 0.15%. Tencent, however, slipped into negative territory. 1

Tencent last reported earnings in November, covering the third quarter. The next major event will be its full-year results and dividend announcement in March.

Macro factors will also shadow the upcoming session. Investors worldwide are focused on U.S. consumer inflation data set for Jan. 13, along with Taiwan Semiconductor Manufacturing Co’s earnings report due Jan. 15, seeking signals on interest rates and the AI investment trend.

The chart shows the market holding HK$610 as a near-term floor. Falling below that would push the stock toward the bottom of its recent range. On the upside, traders eye HK$617–HK$620 as the first zone for a bounce.

Buybacks won’t provide a safety net. If risk appetite drops or China internet earnings fall short on ads or games, demand can evaporate quickly, sending the stock lower despite corporate purchases.

When trading kicks off Monday, all eyes will be on whether Tencent continues snapping up shares around HK$610 and if tech sentiment stays steady. The key date, though, is March 18, when the board reviews results and might announce a final dividend.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY
Previous Story

Eli Lilly stock slides 2%: Zepbound trial data, TuneLab AI tie-up and what’s next for LLY

Visa stock dips as shareholder filing flags AI deepfake payment risk ahead of vote
Next Story

Visa stock dips as shareholder filing flags AI deepfake payment risk ahead of vote

Go toTop